Harvard's Pieter Cohen and Johns Hopkins' Caleb Alexander advise against unapproved injectable peptides as HHS reportedly plans to let pharmacies compound some.
Recap by typeshit. Full story at CNBC.
A University of Iowa chemist found no peptide in a Brooklyn corner-store vial, and another expert flagged at least 13 bacterial colonies that could cause infection.
WebMD notes that eating less on a GLP-1 can mean missing some nutrients, and suggests asking your doctor about nutrition while on the drug.
The FDA notice says the pharmacy can't assure the vials are sterile. Check the full details to see which compounded products are affected.
Doctors describe a patient who developed a bowel obstruction after moving from tirzepatide to semaglutide unsupervised, following a long break in treatment.
Morse says bar and restaurant workers have seen younger adults drink less, framing it as a broad change in the alcohol industry.
In 367 adults with type 2 diabetes, the top combo dose beat 14.8% on tirzepatide alone at 48 weeks. Lilly plans phase 3 by late 2026.
Loading…